Loading...
Publication: Bacille Calmette-Guerin (BCG) vaccine for preventing SARS-CoV-2 infection or improving COVID-19 outcomes: Evidence review of clinical benefits and harms
Blockman, M Cohen, K De Waal, R Gray, A Kredo, T Maartens, G Nel, J Parrish, A Rees, H Reubenson, G
Blockman, M
Cohen, K
De Waal, R
Gray, A
Kredo, T
Maartens, G
Nel, J
Parrish, A
Rees, H
Reubenson, G
Citations
Altmetric:
Abstract
Description
The BCG vaccine, a live attenuated strain of Mycobacterium bovis, was first used in humans in 19211. BCG vaccination was introduced in South Africa in 1973 and is given intradermally at birth using the Danish BCG strain2. There are several strains of the vaccine, which have different microbiological properties.
Date
2020-05-27
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Bacille Calmette-Guerin,Vaccine for SARS-Cov-2,BGC vaccine,COVID-19 Prevention,Vaccine for COVID-19,COVID-19 treatment,Medicine,Benefits and harms of BCG prevention and treatment,Patients with COVID-19,Microbiology